Indivior (INDV) Scheduled to Post Earnings on Thursday

Indivior (NASDAQ:INDV) is scheduled to announce its earnings results before the market opens on Thursday, April 25th. Analysts expect the company to announce earnings of $0.38 per share for the quarter. Indivior has set its FY 2024 guidance at EPS.

Indivior (NASDAQ:INDV) last posted its quarterly earnings results on Thursday, February 22nd. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.15. The business had revenue of $293.00 million during the quarter, compared to analyst estimates of $260.00 million. Indivior had a net margin of 0.18% and a return on equity of 538.18%. On average, analysts expect Indivior to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Indivior Price Performance

NASDAQ INDV opened at $18.54 on Tuesday. The company has a 50 day simple moving average of $20.46 and a 200-day simple moving average of $18.36. The firm has a market capitalization of $2.56 billion, a price-to-earnings ratio of -926.54 and a beta of 0.46. Indivior has a 52-week low of $14.38 and a 52-week high of $26.50.

Analyst Upgrades and Downgrades

Separately, Craig Hallum assumed coverage on shares of Indivior in a research report on Wednesday, April 3rd. They issued a “buy” rating and a $37.00 price target for the company.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.